Cessation of Development of Antibody Compounds. If, as a result of development decisions made by Genentech or the JSC, no Antibody Compound is under research or development as part of the Collaboration for a period of [**] months or more and:
Appears in 4 contracts
Samples: And License Agreement, And License Agreement (Curis Inc), And License Agreement (Curis Inc)
